Donepezil is a choline esterase inhibitor used to treat Alzheimer’s disease and dementia with Lewy bodies, and the drug shows IKr blocking action with various critical side effects including QT prolongation and lethal ventricular arrhythmias (Kho et al., 2021). The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.